Retroperitoneal bulky histiocytic sarcoma successfully treated with induction chemotherapy followed by curative surgery

1Citations
Citations of this article
11Readers
Mendeley users who have this article in their library.

Abstract

Histiocytic sarcoma (HS) is a rare hematopoietic neoplasm. We report a patient with HS treated with induction chemotherapy followed by curative surgery. A 50-year-old man was referred to our hospital because of a retroperitoneal tumor. A computed tomography scan revealed a bulky retroperitoneal mass, infiltrating the surrounding organ. An excisional biopsy confirmed the diagnosis of HS. The tumor shrunk after multidrug chemotherapy. However, positron emission tomography showed uptake of fludeoxyglucose in the residual tumor. He underwent right nephrectomy to remove the tumor. Pathological examination showed complete response. Surgery combined with induction chemotherapy may be an effective way to manage HS.

Cite

CITATION STYLE

APA

Oto, M., Maeda, A., Nose, T., Ueda, Y., Uneda, S., Inadome, A., … Yoshida, M. (2017). Retroperitoneal bulky histiocytic sarcoma successfully treated with induction chemotherapy followed by curative surgery. Internal Medicine, 56(20), 2765–2768. https://doi.org/10.2169/internalmedicine.8000-16

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free